CPRI CLASS ACTION NOTICE: Lose Money on Your Capri Holdings Investment? You may have been affected by Fraud – Contact BFA Law

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Capri Holdings Limited (NYSE:CPRI), Tapestry, Inc., and certain of Capri and Tapestry’s senior executives for potential violations of the federal securities laws. If you invested in Capri, […]

APLT CLASS ACTION NOTICE: Lose Money on Your Applied Therapeutics Investment? You may have been affected by Fraud – Contact BFA Law

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are

FTAI CLASS ACTION NOTICE: Lose Money on Your FTAI Aviation Ltd. Investment? You may have been affected by Fraud – Contact BFA Law

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against FTAI Aviation Ltd. (NASDAQ:FTAI) and certain of its senior executives for potential violations of the federal securities laws. If you invested in FTAI Aviation, you are encouraged

NEVADA CANYON RESPONDS TO OTC MARKETS REQUEST ON RECENT PROMOTIONAL ACTIVITY

(PinkSheets:NGLD),(Pinksheets:NGLD), Reno, Nevada, Jan. 22, 2025 (GLOBE NEWSWIRE) — Nevada Canyon Gold Corp. (OTCQX: NGLD) (The “Company” or “Nevada Canyon”) announces it has been requested by OTC Markets Group Inc. (“OTC Markets“) to issue this statement about promotional activity concerning its common shares (the “Common Shares“) traded on the OTCQX Market (operated by OTC Markets).

BIOA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BIOA Investors with Losses to Contact the Firm

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQ: BIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26,

Nuvia Named 2025 Dental Implant Restoration Company of the Year

Healthcare Business Review, a leading publication in the healthcare and dental space, recognizesNuvia Dental Implant Center for a second consecutive year. https://mma.prnewswire.com/media/2493612/Nuvia_Dental_Implant_Center_New_Logo.jpg As a leader in the dental implantology field, Nuvia Dental Implant Center has been named 2025 Dental Implant Restoration Company of the Year Award by the Healthcare Business Review. Recognized for their life-changing

Duke Energy continues to manage the power grid through sustained cold conditions

— Company also shares tips on ways to save energy and money as temperatures drop this week;b-roll of energy-saving tips available here As prolonged freezing temperatures continue, Duke Energy continues executing a detailed plan to manage the power grid as customer demand increases. Customer demand is anticipated to peak on Thursday across the Carolinas and

Bronstein, Gewirtz & Grossman, LLC Encourages Zeta Global Holdings Corp. (ZETA) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zeta Global Holdings Corp. ("Zeta" or "the Company") (NYSE:ZETA). Investors who purchased Zeta securities prior to February 27, 2024, and continue to hold to the present, are encouraged to

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. – SYRE

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spyre and certain of its officers and/or directors

Scroll to Top